植入HeartMate 3（HM3）左心室辅助装置（LVAD）的患者中，感染并发症较为常见。尽管存在这些问题，但部分患有LVAD相关感染的患者最终仍会被考虑进行心脏移植（HT）。HM3 LVAD相关感染对心脏移植后预后的影响仍不明确。 方法 我们回顾了2014年1月1日至2024年12月31日 ...

本研究分析ARIES-HM3试验中背景药物对HM3 LVAD患者出血等并发症的影响，发现RAAS抑制剂降低出血风险（HR 0.61），但其他心血管药物（如钙通道阻滞剂、PDE5抑制剂）未显著影响结局。背景药物与雷尼替丁无交互作用（P>0.05），但独立使用RAAS抑制剂可降低HRAE风险。

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of ...

PHILADELPHIA -- Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ...

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of ...

PHILADELPHIA, PA—Adding to a growing list of medical situations in which aspirin appears to do more harm than good, the ARIES HM3 trial has shown that it can safely be dropped from the antithrombotic ...

A groundbreaking study recently published in JAMA indicates that aspirin may not be necessary as part of an antithrombotic regimen for patients with a fully magnetically levitated left ventricular ...

Tecarfarin, which recently received Orphan Drug Designation from the FDA for the prevention of thromboembolism and thrombosis in patients with an implanted mechanical circulatory support device, has ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved updated labeling to remove aspirin as part of routine care after implant of Abbott’s fully ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant exclusively ...

Please provide your email address to receive an email when new articles are posted on . In patients with advanced HF on a LVAD, removing aspirin from the antithrombotic regimen was safe. Avoiding ...

New research highlighted how aspirin is unnecessary in antithrombotic regimens for patients with advanced heart failure and fully magnetically levitated left ventricular assist devices (LVADs). Among ...